For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $269.95 in the prior trading day, Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) closed at $265.29, down -1.73%. In other words, the price has decreased by -$1.73 from its previous closing price. On the day, 0.95 million shares were traded. ALNY stock price reached its highest trading level at $268.79 during the session, while it also had its lowest trading level at $264.23.
Ratios:
Our goal is to gain a better understanding of ALNY by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.31 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 2130.59. For the most recent quarter (mrq), Quick Ratio is recorded 2.69 and its Current Ratio is at 2.75. In the meantime, Its Debt-to-Equity ratio is 84.27 whereas as Long-Term Debt/Eq ratio is at 80.17.
On August 16, 2024, Goldman Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $198 to $370.
Goldman Downgraded its Buy to Neutral on February 16, 2024, while the target price for the stock was maintained at $173.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 20 ’24 when Greenstreet Yvonne sold 15,000 shares for $280.00 per share. The transaction valued at 4,200,000 led to the insider holds 73,441 shares of the business.
Greenstreet Yvonne bought 15,000 shares of ALNY for $4,200,000 on Aug 20 ’24. On Aug 12 ’24, another insider, Fitzgerald Kevin Joseph, who serves as the CSO & EVP, Head of Research of the company, sold 22,025 shares for $270.99 each. As a result, the insider received 5,968,516 and left with 12,881 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALNY now has a Market Capitalization of 34815864832 and an Enterprise Value of 34163304448. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.33 while its Price-to-Book (P/B) ratio in mrq is 1056.43. Its current Enterprise Value per Revenue stands at 16.309 whereas that against EBITDA is -258.527.
Stock Price History:
Over the past 52 weeks, ALNY has reached a high of $304.39, while it has fallen to a 52-week low of $141.98. The 50-Day Moving Average of the stock is -3.42%, while the 200-Day Moving Average is calculated to be 28.10%.
Shares Statistics:
The stock has traded on average 820.38K shares per day over the past 3-months and 824240 shares per day over the last 10 days, according to various share statistics. A total of 128.98M shares are outstanding, with a floating share count of 127.83M. Insiders hold about 0.90% of the company’s shares, while institutions hold 93.70% stake in the company. Shares short for ALNY as of 1728950400 were 4842259 with a Short Ratio of 5.90, compared to 1726185600 on 4452892. Therefore, it implies a Short% of Shares Outstanding of 4842259 and a Short% of Float of 4.32.
